• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物诱导的血小板减少症:关注血小板凋亡。

Drug-induced thrombocytopenia: Focus on platelet apoptosis.

机构信息

Centre for Blood Research, University of British Columbia, Vancouver, Canada; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada.

Centre for Blood Research, University of British Columbia, Vancouver, Canada; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, Canada; Faculty of Dentistry, University of British Columbia, Vancouver, Canada.

出版信息

Chem Biol Interact. 2018 Mar 25;284:1-11. doi: 10.1016/j.cbi.2018.01.015. Epub 2018 Feb 2.

DOI:10.1016/j.cbi.2018.01.015
PMID:29410286
Abstract

Thrombocytopenia is a serious and potentially fatal complication of drug therapy that results either from a decrease in bone marrow platelet production or the excessive destruction of circulating platelets. Although multiple mechanisms are responsible for deregulated platelet clearance, the role of programmed platelet death (apoptosis) in drug-induced thrombocytopenia has been relatively under-investigated until recently. Here we review apoptotic signaling pathways in platelets, with a focus on current data that provide mechanistic insights into drug-induced apoptosis and thrombocytopenia.

摘要

血小板减少症是药物治疗的一种严重且潜在致命的并发症,其原因要么是骨髓血小板生成减少,要么是循环血小板过度破坏。虽然有多种机制导致血小板清除失调,但程序性血小板死亡(细胞凋亡)在药物诱导的血小板减少症中的作用直到最近才得到相对较少的研究。在这里,我们综述了血小板中的凋亡信号通路,并重点介绍了目前提供药物诱导凋亡和血小板减少症机制见解的数据。

相似文献

1
Drug-induced thrombocytopenia: Focus on platelet apoptosis.药物诱导的血小板减少症:关注血小板凋亡。
Chem Biol Interact. 2018 Mar 25;284:1-11. doi: 10.1016/j.cbi.2018.01.015. Epub 2018 Feb 2.
2
Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.骨髓增生异常综合征中的血小板凋亡和激动剂介导的激活。
Thromb Haemost. 2013 May;109(5):909-19. doi: 10.1160/TH12-09-0670. Epub 2013 Feb 14.
3
Discriminative value of platelet size indices for the identification of the mechanism of chemotherapy-induced thrombocytopenia.血小板大小指数对化疗诱导性血小板减少症发病机制的鉴别价值。
Biomarkers. 2011 Feb;16(1):51-7. doi: 10.3109/1354750X.2010.526243. Epub 2010 Oct 27.
4
Reticulated platelets in the evaluation of thrombopoietic disorders.网织血小板在血小板生成障碍评估中的应用
Arch Pathol Lab Med. 1993 Jun;117(6):606-10.
5
Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in mice.小鼠放化疗诱导血小板减少症的药效学模型。
J Pharmacokinet Pharmacodyn. 2015 Dec;42(6):709-20. doi: 10.1007/s10928-015-9440-2. Epub 2015 Sep 4.
6
Regulation of platelet lifespan by apoptosis.通过细胞凋亡对血小板寿命的调节。
Platelets. 2016 Sep;27(6):497-504. doi: 10.3109/09537104.2016.1161739. Epub 2016 Apr 21.
7
Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology.治疗药物诱导的血小板凋亡:药物毒理学中的一个被忽视的问题。
Arch Toxicol. 2014 Feb;88(2):185-98. doi: 10.1007/s00204-013-1185-3. Epub 2013 Dec 21.
8
Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production.序贯给予高亲和力 CXCR4 拮抗剂 BKT140 可促进巨核细胞生成和血小板生成。
Br J Haematol. 2013 Oct;163(2):248-59. doi: 10.1111/bjh.12501. Epub 2013 Aug 1.
9
Linezolid-Induced Thrombocytopenia Is Caused by Suppression of Platelet Production via Phosphorylation of Myosin Light Chain 2.利奈唑胺诱导的血小板减少是由肌球蛋白轻链2磷酸化抑制血小板生成所致。
Biol Pharm Bull. 2016;39(11):1846-1851. doi: 10.1248/bpb.b16-00427.
10
Doxorubicin-induced platelet cytotoxicity: a new contributory factor for doxorubicin-mediated thrombocytopenia.阿霉素诱导的血小板细胞毒性:阿霉素介导的血小板减少症的一个新的促成因素。
J Thromb Haemost. 2009 Jul;7(7):1172-83. doi: 10.1111/j.1538-7836.2009.03477.x. Epub 2009 May 8.

引用本文的文献

1
Platelet Transfusion for Patients with Cancer: An Update.癌症患者的血小板输注:最新进展
Transfus Med Hemother. 2025 Jun 12. doi: 10.1159/000546566.
2
Development and external validation of a machine learning model for predicting drug-induced immune thrombocytopenia in a real-world hospital cohort.用于预测真实世界医院队列中药物性免疫性血小板减少症的机器学习模型的开发与外部验证
BMC Med Inform Decis Mak. 2025 Jul 15;25(1):265. doi: 10.1186/s12911-025-03107-3.
3
Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia Accompanied with Very Severe Thrombocytopenia.
遗传性出血性毛细血管扩张症伴极重度血小板减少症的胃肠道出血
Am J Case Rep. 2025 Jun 10;26:e948068. doi: 10.12659/AJCR.948068.
4
Romiplostim in chemotherapy-induced thrombocytopenia: A review of the literature.罗米司亭在化疗引起的血小板减少症中的应用:文献复习。
Cancer Med. 2024 Aug;13(15):e7429. doi: 10.1002/cam4.7429.
5
Physiological platelet aggregation assay to mitigate drug-induced thrombocytopenia using a microphysiological system.使用微生理系统进行生理血小板聚集测定以减轻药物诱导的血小板减少症。
Sci Rep. 2024 Jun 19;14(1):14109. doi: 10.1038/s41598-024-64063-y.
6
Drug-Induced Thrombocytopenia Due to Nintedanib during Treatment of Idiopathic Pulmonary Fibrosis.尼达尼布治疗特发性肺纤维化导致的药物性血小板减少症。
Medicina (Kaunas). 2023 May 22;59(5):999. doi: 10.3390/medicina59050999.
7
Apoptosis in platelets is independent of the actin cytoskeleton.血小板凋亡不依赖于肌动蛋白细胞骨架。
PLoS One. 2022 Nov 15;17(11):e0276584. doi: 10.1371/journal.pone.0276584. eCollection 2022.
8
Association of Platelet Desialylation and Circulating Follicular Helper T Cells in Patients With Thrombocytopenia.血小板去唾液酸化与循环滤泡辅助性 T 细胞在血小板减少症患者中的相关性。
Front Immunol. 2022 Apr 1;13:810620. doi: 10.3389/fimmu.2022.810620. eCollection 2022.
9
Mechanisms involved in the development of thrombocytopenia in patients with COVID-19.与 COVID-19 患者血小板减少症发展相关的机制。
Thromb Res. 2020 Sep;193:110-115. doi: 10.1016/j.thromres.2020.06.008. Epub 2020 Jun 5.